Jinfu Xu
Overview
Explore the profile of Jinfu Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng R, Li Z, Fang W, Lou H, Liu F, Sun Q, et al.
Cell Rep Med
. 2025 Jan;
6(2):101923.
PMID: 39848245
Non-tuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic progressive lung disease that is increasing in incidence. Host genetic factors are associated with NTM-PD susceptibility. However, the heritability of NTM-PD is...
2.
Zhang J, Dhlamini Q, Guo Q, Quan M, Wu J, Lyu H, et al.
J Respir Biol Transl Med
. 2024 Dec;
1(4).
PMID: 39712874
Respiratory diseases pose a major public health challenge globally, necessitating collaborative efforts between basic researchers and clinicians for effective solutions. China, which is heavily impacted by a broad spectrum of...
3.
Wang L, Wu Y, Xu J, Wei P, Lu H
J Thorac Dis
. 2024 Oct;
16(9):5650-5662.
PMID: 39444907
Background: Lung abscess in the apical segment of the lung is not rare and is often underestimated in clinical practice. However, the clinical features of apical segment lung abscess (AL)...
4.
Su Y, Zhang Y, Zhang D, Xu J
Aging Clin Exp Res
. 2024 Oct;
36(1):205.
PMID: 39395132
Background: Sarcopenia (SP) is an aging-related loss of muscle mass and function, affecting the respiratory system. However, the causality of the association between sarcopenia on lung diseases remains elusive. Methods:...
5.
Ma J, Wu C, Xu J
Adv Healthc Mater
. 2024 Aug;
13(29):e2401025.
PMID: 39206615
The challenge of the treatment of end-stage lung disease poses an urgent clinical demand for lung tissue engineering. Over the past few years, various lung tissue-engineered constructs are developed for...
6.
Yang Z, Zhao Y, Zhang X, Huang L, Wang K, Sun J, et al.
ACS Nano
. 2024 Jul;
18(32):21221-21235.
PMID: 39079080
The mechanical properties of nanoparticles play a crucial role in regulating nanobiointeractions, influencing processes such as blood circulation, tumor accumulation/penetration, and internalization into cancer cells. Consequently, they have a significant...
7.
Ye F, Cai S, Cao B, Cheng L, Fan H, Huang Y, et al.
J Thorac Dis
. 2024 Jul;
16(6):4016-4029.
PMID: 38983176
Background: Invasive fungal disease (IFD) has become a serious threat to human health in China and around the world, with high mortality and morbidity. Currently, the misdiagnosis rate of IFD...
8.
Li Y, Zhu D, Sun S, Chang X, Cao Z, Yang Y, et al.
Int J Antimicrob Agents
. 2024 Jun;
64(2):107235.
PMID: 38851462
Background: Nemonoxacin malate is a novel non-fluorinated quinolone for oral and intravenous (IV) administration. This phase 3, multicentre, randomised, double-blind, double-dummy, parallel-controlled clinical trial (NCT02205112) evaluated the efficacy and safety...
9.
Su Y, Zhang Y, Xu J
BMC Pulm Med
. 2024 May;
24(1):240.
PMID: 38750544
Background: Previous research has emphasized the potential benefits of anti-diabetic medications in inhibiting the exacerbation of Chronic Obstructive Pulmonary Disease (COPD), yet the role of anti-diabetic drugs on COPD risk...
10.
Su Y, Zhang Y, Chai Y, Xu J
Front Immunol
. 2024 Apr;
15:1343480.
PMID: 38660310
Background: Previous studies have demonstrated that autoimmune diseases are closely associated with bronchiectasis (BE). However, the causal effects between autoimmune diseases and BE remain elusive. Methods: All summary-level data were...